Reply: Intra-patient heterogeneity of BRAF mutation status: fact or fiction? - Wikidata - awgldk - TriplyDB

Reply: Intra-patient heterogeneity of BRAF mutation status: fact or fiction?

Reply: Intra-patient heterogeneity of BRAF mutation status: fact or fiction?

http://www.wikidata.org/entity/Q42947925

about

Reply: Intra-patient heterogeneity of BRAF mutation status: fact or fiction?

http://www.wikidata.org/entity/Q42947925

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Reply: Intra-patient heterogeneity of BRAF mutation status: fact or fiction?

@en

Reply: Intra-patient heterogeneity of BRAF mutation status: fact or fiction?

@nl

type

label

Reply: Intra-patient heterogeneity of BRAF mutation status: fact or fiction?

@en

Reply: Intra-patient heterogeneity of BRAF mutation status: fact or fiction?

@nl

prefLabel

Reply: Intra-patient heterogeneity of BRAF mutation status: fact or fiction?

@en

Reply: Intra-patient heterogeneity of BRAF mutation status: fact or fiction?

@nl

P1433

Q42947925-FF530FAD-ADCB-4555-9740-E0BE5555F302

P1476

Q42947925-B4CBDA6F-3468-4EDC-B9AB-9E8CD514C60D

P2093

Q42947925-74AD8711-74B9-408D-9481-31694439EEFA

Q42947925-7A4660DB-5713-4349-96AE-2CA4EDE701E2

Q42947925-9C0791F2-7E58-49EA-8201-6EA9192DC5D0

Q42947925-E46278B4-EBA3-4D60-9F59-FDC962E7F853

P2860

Q42947925-02DF4862-FCDD-4129-B26F-02A29A374A42

Q42947925-0BBC97F8-C1C3-4262-9C5C-400750588C82

Q42947925-1ECA41EB-0E41-4E79-9714-D1B1B4DE7768

Q42947925-3A0A96E0-A7E5-47AF-BCD8-731D01E61E3C

Q42947925-3D22DA87-8E3F-47E7-BB04-23965B4FC4F9

Q42947925-43C64294-26D0-4110-9687-501C8B7CB099

Q42947925-4968AEFC-5268-4999-A831-75E1F628A81F

Q42947925-4AD5A6AA-92D9-414C-B30C-7B96DD4AA364

Q42947925-50371C2A-3BA9-42C0-B950-C66A165131AE

Q42947925-5768A4F6-AE36-4872-A40C-807A2DA5F368

P2888

Q42947925-5D1A5D75-894A-47A6-B602-A5890ABDF3CB

P304

Q42947925-D1C3EDA1-8FE5-4BDA-A0CA-DC6EA671381D

P31

Q42947925-E9E08E6E-0BAC-4098-B886-E9C481B31A8E

P356

Q42947925-8729F1BD-D2F1-4BF0-BB08-E7E0102B632C

P407

Q42947925-19568B32-B2F0-4861-8901-2265AAAD5D8B

P433

Q42947925-D99FC4AD-B61D-4CD7-AC0C-ACB7B1872C27

P478

Q42947925-1B46EBE9-44C9-464E-A6AB-E63FE3262AE1

P577

Q42947925-F7B91363-AC82-4839-8657-53CA7EB7007A

P5875

Q42947925-1076971D-858F-46A2-B683-47676BE8B5DA

P698

Q42947925-FF15F256-6278-45E1-93D4-9DE6A362174C

P932

Q42947925-CCCC7842-875E-49F3-8D6E-E8B6A38AB828

P356

P1433

British Journal of Cancer

P1476

Reply: Intra-patient heterogeneity of BRAF mutation status: fact or fiction?

@en

P2093

A Hartmann

http://www.w3.org/2001/XMLSchema#string

G Schuler

http://www.w3.org/2001/XMLSchema#string

L Heinzerling

http://www.w3.org/2001/XMLSchema#string

R Schneider-Stock

http://www.w3.org/2001/XMLSchema#string

P2860

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

Constitutive activation of the Ras-Raf signaling pathway in metastatic melanoma is associated with poor prognosis

BRAF(L597) mutations in melanoma are associated with sensitivity to MEK inhibitors

Intra- and inter-tumor heterogeneity of BRAF(V600E))mutations in primary and metastatic melanoma

Tumor homogeneity between primary and metastatic sites for BRAF status in metastatic melanoma determined by immunohistochemical and molecular testing

Multiplex mutation screening by mass spectrometry evaluation of 820 cases from a personalized cancer medicine registry

Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma.

Application of a BRAF pyrosequencing assay for mutation detection and copy number analysis in malignant melanoma.

Rare BRAF mutations in melanoma patients: implications for molecular testing in clinical practice.

Inhibition of both BRAF and MEK in BRAF(V600E) mutant melanoma restores compromised dendritic cell (DC) function while having differential direct effects on DC properties.

P2888

P304

1679-1680

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2014.247

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262386078

http://www.w3.org/2001/XMLSchema#string

P698

24832175

http://www.w3.org/2001/XMLSchema#string

P932

4200080

http://www.w3.org/2001/XMLSchema#string